COP · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $51.82B | $49.42B | $48.52B | $61.05B | $34.59B | $13.66B | $32.57B | $36.42B |
| Cost of Revenue | $22.32B | $20.01B | $21.98B | $33.97B | $18.16B | $8.08B | $11.84B | $14.29B |
| Research & Development | $78.00M | $81.00M | $81.00M | $71.00M | $62.00M | $75.00M | $82.00M | $78.00M |
| Selling, General & Administrative | $893.00M | $1.16B | $705.00M | $623.00M | $719.00M | $430.00M | $556.00M | $401.00M |
| Interest Expense | $1.18B | $941.00M | $824.00M | $791.00M | $887.00M | $788.00M | $799.00M | $838.00M |
| Other Income / (Expense) | -$20.00M | -$181.00M | -$2.00M | $47.00M | -$102.00M | -$13.00M | $1.36B | $173.00M |
| Income Before Taxes | $12.66B | $13.67B | $16.29B | $28.23B | $12.71B | -$3.14B | $9.52B | $9.97B |
| Provision for Income Taxes | $4.67B | $4.43B | $5.33B | $9.55B | $4.63B | -$485.00M | $2.27B | $3.67B |
| Net Income | $7.99B | $9.24B | $10.96B | $18.68B | $8.08B | -$2.70B | $7.19B | $6.26B |
| Basic EPS | $6.36 | $7.82 | $9.08 | $14.62 | $6.09 | -$2.51 | $6.43 | $5.36 |
| Diluted EPS | $6.35 | $7.81 | $9.06 | $14.57 | $6.07 | -$2.51 | $6.40 | — |
| Basic Shares Outstanding | 1.25B | 1.18B | 1.20B | 1.27B | 1.32B | 1.08B | 1.12M | 1.17M |
| Diluted Shares Outstanding | 1.25B | 1.18B | 1.21B | 1.28B | 1.33B | 1.08B | 1.12M | 1.18M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $9.20 | $8.41 | $10.55 | 7 | ↑1 ↓4 |
| Dec 2027 | $8.14 | $6.44 | $9.04 | 7 | ↑0 ↓5 |
| Dec 2028 | $9.10 | $7.92 | $10.28 | 2 | ↑0 ↓0 |